ClinConnect ClinConnect Logo
Search / Trial NCT06884696

Study of Placental Inflammation in Gestational Diabetes

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Mar 18, 2025

Trial Information

Current as of May 09, 2025

Active, not recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how inflammation in the placenta may affect women with gestational diabetes mellitus (GDM), a type of diabetes that occurs during pregnancy. Specifically, the researchers are looking at a protein called NLRP3 and a chemical messenger that helps regulate inflammation. Understanding this could help improve care for women with GDM and their babies.

To be eligible for this study, women must be over 18 years old, have a singleton pregnancy (meaning they are pregnant with one baby), and have been diagnosed with gestational diabetes but have an otherwise uncomplicated pregnancy. Unfortunately, women under 18, those with infections, multiple pregnancies, or a history of cancer cannot participate. While the trial is currently active, it is not recruiting new participants at this time. If eligible women were to join, they would likely undergo tests and monitoring related to their condition, contributing valuable information to enhance understanding of gestational diabetes.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women with gestational diabetes mellitus
  • Women with uncomplicated pregnancy
  • Age \>18 years
  • Singleton pregnancy
  • Exclusion Criteria:
  • Age \< 18 years
  • Infections (HIV,HCV)
  • Multiple pregnancy
  • Cancer

About Fondazione Policlinico Universitario Agostino Gemelli Irccs

Fondazione Policlinico Universitario Agostino Gemelli IRCCS is a leading research and healthcare institution based in Rome, Italy, renowned for its commitment to advancing medical science and improving patient care. As a prominent academic medical center affiliated with the Catholic University of the Sacred Heart, it integrates clinical practice, education, and research, fostering innovation in various fields of medicine. The foundation conducts a wide range of clinical trials aimed at developing new therapies and enhancing treatment protocols, with a focus on translational research that bridges the gap between laboratory discoveries and patient care. Its multidisciplinary approach and dedication to high ethical standards position it as a key player in the landscape of clinical research and healthcare improvement in Italy and beyond.

Locations

Rome, , Italy

Patients applied

0 patients applied

Trial Officials

Chiara Tersigni

Principal Investigator

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported